← Evidence map

ReviewAntibody therapeutics2022

Engineering antibody and protein therapeutics to cross the blood-brain barrier.

Peng Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

44 papers cite it

2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36540309